Telluride Asset Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Telluride Asset Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$209K	Buy	+4,700	New	+$192K	0.18%	199

Other funds holding CBPO

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EMR

Errol M. Rudman $148M AUM 19.65% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

LBA

Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Telluride Asset Management's CBPO Position: Q2 2014 in Review

Telluride Asset Management opened a new position in China Biologic Products Holdings, Inc. (CBPO) in Q2 2014: 4,700 shares worth $209K. The stake represents 0.18% of the portfolio and ranks #199 among its holdings.

47 funds tracked by Wall St. Rank hold CBPO as of Q2 2014.

Telluride Asset Management held 4,700 shares of China Biologic Products Holdings, Inc. worth $209K as of Q2 2014.
China Biologic Products Holdings, Inc. was a new Telluride Asset Management position in Q2 2014.
China Biologic Products Holdings, Inc. made up 0.18% of Telluride Asset Management's portfolio in Q2 2014, its #199 holding.
47 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2014.

Based on Telluride Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.